Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Year in Review
  • Published:

Diabetic nephropathy in 2010

Alleviating the burden of diabetic nephropathy

Many patients with diabetic nephropathy progress to end-stage renal disease. New research in disease detection, diagnosis, and novel treatments will hopefully alleviate the burden of diabetic nephropathy in the future.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Papale, M. et al. Urine proteome analysis may allow non-invasive differential diagnosis of diabetic nephropathy. Diabetes Care 33, 2409–2415 (2010).

    Article  CAS  Google Scholar 

  2. Overgaard, A. J. et al. Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy Proteome Science 8, 4 (2010).

    Article  Google Scholar 

  3. Babaei-Jadidi, R., Karachalias, N., Ahmed, N., Battah, S. & Thornalley, P. J. Prevention of incipient diabetic nephropathy by high-dose thiamine and benfotiamine. Diabetes 52, 2110–2120 (2003).

    Article  CAS  Google Scholar 

  4. Alkhalaf, A. et al. A double-blind, randomized, placebo controlled clinical trial on benfotiamine treatment in patietns with diabetic nephropathy. Diabetes Care 33, 1598–1601 (2010).

    Article  CAS  Google Scholar 

  5. Rabbani, N. et al. High-dose thiamine therapy for patients with type 2 diabetes and microalbuminuria: a randomised, double-blind placebo-controlled pilot study. Diabetologia 52, 208–212 (2009).

    Article  CAS  Google Scholar 

  6. Ismail-Beigi, F. et al. Effect of intensive treatment of hyperglycemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376, 419–430 (2010).

    Article  Google Scholar 

  7. Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R. & Neil, H. A. 10-year follow-up of intensive glucose control type 2 diabetes. N. Engl. J. Med. 359, 1577–1589 (2008).

    Article  CAS  Google Scholar 

  8. Zoungas, A. et al. Intensive glucose control is renoprotective in type 2 diabetes: new analyses from ADVANCE. Diabetologia 53 (Suppl. 1), S98 (2010).

    Google Scholar 

  9. Duckworth, W. et al. Glucose control and vascular complications in veterans with type 2 diabetes. N. Engl. J. Med. 360, 129–139 (2009).

    Article  CAS  Google Scholar 

  10. Tessari, P. et al. Nitric oxide synthesis is reduced in subjects with type 2 diabetes and nephropathy. Diabetes 59, 2152–2159 (2010).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stephen P. Gray.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gray, S., Cooper, M. Alleviating the burden of diabetic nephropathy. Nat Rev Nephrol 7, 71–73 (2011). https://doi.org/10.1038/nrneph.2010.176

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2010.176

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing